User login
Article Type
Changed
Thu, 05/14/2020 - 15:15
Display Headline
First-Line Treatment of IDA in NDD-CKD
In this supplement to Internal Medicine News, Kamyar Kalantar-Zadeh, MD, MPH, PhD, discusses a first-line treatment option for iron deficiency anemia (IDA) in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Topics include:
- The interplay between IDA and CKD
- Recognizing IDA in patients with CKD
- First-line treatment efficacy and safety information
Sponsor
This promotional article was developed in conjunction with and sponsored by Dai…
Publications
Sections
Sponsor
This promotional article was developed in conjunction with and sponsored by Dai…
Sponsor
This promotional article was developed in conjunction with and sponsored by Dai…
In this supplement to Internal Medicine News, Kamyar Kalantar-Zadeh, MD, MPH, PhD, discusses a first-line treatment option for iron deficiency anemia (IDA) in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Topics include:
- The interplay between IDA and CKD
- Recognizing IDA in patients with CKD
- First-line treatment efficacy and safety information
In this supplement to Internal Medicine News, Kamyar Kalantar-Zadeh, MD, MPH, PhD, discusses a first-line treatment option for iron deficiency anemia (IDA) in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Topics include:
- The interplay between IDA and CKD
- Recognizing IDA in patients with CKD
- First-line treatment efficacy and safety information
Publications
Publications
Article Type
Display Headline
First-Line Treatment of IDA in NDD-CKD
Display Headline
First-Line Treatment of IDA in NDD-CKD
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica
Conference Recap Checkbox
Not Conference Recap